DreaMed Diabetes, Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
DreaMed Diabetes, Ltd. - overview
Established
2014
Location
Petah Tikva, -, Israel
Primary Industry
Medical Devices & Equipment
About
Based in Petah Tikva, Israel, and founded in 2014 by Chief Executive Officer Eran Atlas and co-founder Ido Mueller, DreaMed Diabetes, Ltd. operates as a health tech company developing solutions for treating diabetes that utilizes event-driven machine learning and logic technologies. In August 2024, DreaMed Diabetes, Ltd. raised USD 3 million in Series B funding led by eHealth Ventures.
DreaMed Diabetes, Ltd. focuses on creating diabetes management through artificial intelligence (AI). The company developed a product known as Endo. Digital, which is a cloud-based platform that supports healthcare providers by offering AI-powered treatment recommendations for both Type 1 and Type 2 diabetes.
Its system integrates with electronic medical records (EMR), automates billing documentation, and engages patients through a mobile app. In addition, the firm leverages technology-based tools for a decision support system that utilizes data from CGM/SMBG (continuous glucose monitoring/self-monitoring of blood glucose) and insulin pumps. The company plans to use the funding from August 2024 to expand operations in the U. S.
, advance its platform, and grow the team. The funds will support scaling efforts, enhance technology, and drive new partnerships, including recent agreements with Abbott and Yale New Haven Health.
Current Investors
Medtronic, Leona M. and Harry B. Helmsley Charitable Trust, Norma Investment
Primary Industry
Medical Devices & Equipment
Sub Industries
Oncology/Cancer Treatment, Medical Devices & Equipment, Scientific Software, Medical Software, Analytics & Performance Software
Website
www.dreamed.ai/
Verticals
Artificial Intelligence, Cloud Computing, HealthTech, Mobile Apps
Company Stage
Series B
Total Amount Raised
Subscriber access only
DreaMed Diabetes, Ltd. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series B | Completed | DreaMed Diabetes, Ltd. | - | ||||||||
| Unspecified Round | Completed | DreaMed Diabetes, Ltd. | - | ||||||||
| Grant | Completed | DreaMed Diabetes, Ltd. | - | ||||||||
| Seed | Completed | DreaMed Diabetes, Ltd. | - |
Displaying 1 - 4 of 4
DreaMed Diabetes, Ltd. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.